Outcomes of Window Therapy with Carboplatin and Ifosfamide for Pediatric Osteosarcoma: A Case Series

• প্রধান লেখক: Hisaki Aiba (লেখক), Michi Kamei (লেখক), Yasuhiko Ito (লেখক), Risa Takeda (লেখক), Satoshi Yamada (লেখক), Hideki Okamoto (লেখক), Katsuhiro Hayashi (লেখক), Shinji Miwa (লেখক), Yohei Kawaguchi (লেখক), Shiro Saito (লেখক), Takao Sakai (লেখক), Hideki Murakami (লেখক), Hiroaki Kimura (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2023-04-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

For the treatment of osteosarcoma, cisplatin (CDDP) can be substituted by carboplatin (CBDCA) to reduce toxicity. We report a single institution experience of CBDCA-based regimen. Two to three cycles of CBDCA + ifosfamide (IFO) therapy (window therapy) were administered as neoadjuvant therapy for os...